Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy

被引:9
作者
Liu, Jie [1 ]
Zhang, Ye [2 ]
Li, Zhengjiang [1 ]
Liu, Shaoyan [1 ]
Li, Huizheng [3 ]
Xu, Zhengang [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Dept Head & Neck Surg Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli,Head & Neck Ward 1, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[3] Dalian Friendship Hosp, Dept Otorhinolaryngol, Dalian, Peoples R China
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; RANDOMIZED-TRIALS; LARYNGEAL-CANCER; SURGERY; THERAPY; FAILURE; CHEMORADIATION;
D O I
10.1186/s13014-017-0900-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. Methods: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. Results: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery <= 6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. Conclusions: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] FACTORS ASSOCIATED WITH LONG-TERM DYSPHAGIA AFTER DEFINITIVE RADIOTHERAPY FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER
    Caudell, Jimmy J.
    Schaner, Philip E.
    Meredith, Ruby F.
    Locher, Julie L.
    Nabell, Lisle M.
    Carroll, William R.
    Magnuson, J. Scott
    Spencer, Sharon A.
    Bonner, James A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 410 - 415
  • [42] Late toxicity after radical treatment for locally advanced head and neck cancer
    Taberna, Miren
    Jose Rullan, Antonio
    Hierro, Cinta
    Navarro, Valentin
    Vazquez, Silvia
    Lozano, Alicia
    Vilajosana, Esther
    Manos, Manel
    Mari, Antonio
    Vinals, Joan
    Mesia, Ricard
    [J]. ORAL ONCOLOGY, 2015, 51 (08) : 795 - 799
  • [43] Patterns of failure after salvage head and neck surgery
    Contrera, Kevin J.
    Mahomva, Chengetai R.
    Sharma, Bhavya K.
    Wei, Wei
    Burkey, Brian B.
    Fritz, Michael
    Ku, Jamie A.
    Lamarre, Eric D.
    Lorenz, Robert R.
    Scharpf, Joseph
    Silver, Natalie
    Sindwani, Raj
    Koyfman, Shlomo A.
    Prendes, Brandon L.
    [J]. ORAL ONCOLOGY, 2024, 157
  • [44] FEASIBILITY STUDY OF MODERATELY ACCELERATED INTENSITY-MODULATED RADIOTHERAPY PLUS CONCURRENT WEEKLY CISPLATIN AFTER INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD-AND NECK CANCER
    Morganti, Alessio G.
    Mignogna, Samantha
    Deodato, Francesco
    Massaccesi, Mariangela
    Cilla, Savino
    Calista, Franco
    Serafini, Giovanni
    Digesu, Cinzia
    Macchia, Gabriella
    Picardi, Vincenzo
    Caravatta, Luciana
    Di Lullo, Liberato
    Giglio, Gianfranco
    Sallustio, Giuseppina
    Piermattei, Angelo
    Cellini, Numa
    Valentini, Vincenzo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1073 - 1080
  • [45] Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy
    Zapata, I
    Alvarez, M.
    Hidalgo, R.
    Pajares, B.
    Garcia-Anaya, M. J.
    Toledo, M. D.
    Trigo, J. M.
    Lupianez-Perez, Y.
    Medina, J. A.
    Jaime Gomez-Millan, J.
    [J]. BMC CANCER, 2019, 19 (01)
  • [46] Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer
    Tallari, Ramanjis Viranna
    Singh, O. P.
    Yogi, Veenita
    Yadav, Suresh
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) : 224 - 229
  • [47] Definitive Altered Fractionation Radiotherapy and Concomitant Weekly Cisplatin for Locally Advanced Head and Neck Cancer
    Boulmay, Brian C.
    Chera, Bhishamjit S.
    Morris, Christopher G.
    Kirwan, Jessica
    Riggs, Charles E.
    Lawson, Michael
    Mendenhall, William M.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 488 - 491
  • [48] Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review
    Iqbal, Muhammad Shahid
    Kelly, Charles
    Kovarik, Josef
    Goranov, Bojidar
    Shaikh, Ghazia
    Morgan, David
    Dobrowsky, Werner
    Paleri, Vinidh
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 126 (03) : 558 - 567
  • [49] Chemotherapy in the treatment of locally advanced head and neck cancer
    Forastiere, Arlene A.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (08) : 701 - 707
  • [50] Induction chemotherapy for locally advanced head and neck cancer
    Calais, G.
    Chapet, S.
    Ruffier-Loubiere, A.
    Bernadou, G.
    [J]. CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 498 - 501